Fagin James A, Petrini John H
Human Oncology and Pathogenesis Program.
Department of Medicine, and.
J Clin Invest. 2020 Nov 2;130(11):5668-5670. doi: 10.1172/JCI142237.
Growth hormone-secreting (GH-secreting) pituitary tumors are driven by oncogenes that induce cAMP signaling. In this issue of the JCI, Ben-Shlomo et al. performed a whole-exome study of pituitary adenomas. GH-secreting tumors had a high frequency of whole chromosome or chromosome arm copy number alterations and were associated with an increase in the tumor protein p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1, which are findings consistent with induction of a response to DNA damage. Further, treatment of mouse pituitary cells with cAMP pathway agonists in vitro and in vivo elicited biomarkers of DNA replication stress or double-strand breaks. The findings of Ben Shlomo et al. indicate that oncoproteins that drive constitutively high cAMP signaling pathway output in susceptible cell types can elicit DNA replication stress and may promote genomic instability.
分泌生长激素(GH分泌)的垂体瘤由诱导cAMP信号传导的致癌基因驱动。在本期《临床研究杂志》中,本 - 什洛莫等人对垂体腺瘤进行了全外显子组研究。分泌GH的肿瘤全染色体或染色体臂拷贝数改变的频率很高,并且与肿瘤蛋白p53和细胞周期蛋白依赖性激酶抑制剂p21WAF1/CIP1的增加有关,这些发现与诱导对DNA损伤的反应一致。此外,在体外和体内用cAMP途径激动剂处理小鼠垂体细胞会引发DNA复制应激或双链断裂的生物标志物。本·什洛莫等人的研究结果表明,在易感细胞类型中驱动组成性高cAMP信号通路输出的癌蛋白可引发DNA复制应激,并可能促进基因组不稳定。